Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics
Roope L, Walsh J, Welland M, Samuel G, Johansen-Berg H, Nobre A, Clare S, Higham H, Campbell J, Denison T, Miller K, Fazel S, Costa M, Farmer A, Knight M, Taylor R, Henderson L, Vaid A, Geddes J, Kiparoglou V, McShane H, Clarke P. Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics. Contemporary Clinical Trials Communications 2025, 45: 101467. PMID: 40235622, PMCID: PMC11999327, DOI: 10.1016/j.conctc.2025.101467.Peer-Reviewed Original ResearchRandomised controlled trialsTrial recruitmentImprove trial recruitmentInvolvement of community partnersIncreasing health inequalitiesActual recruitment processCohort of participantsHigh quality evidenceGold standard evidenceHealth inequalitiesCommunity partnersImprove recruitmentRecruitment processQuality evidenceEvidence baseNon-monetary incentivesStandard evidenceReduce inequalitiesFinancial incentivesControlled TrialsFunding streamsPublic healthClinical researchReal-world populationTrials
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply